Device Trial Radar · NCT07947433
Effect of taVNS on Post-stroke Dysphagia
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Mar 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Cairo UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 19, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 45 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study investigates the effect of transcutaneous auricular vagus nerve stimulation (taVNs) on dysphagia rehabilitation in sub-acute stroke patients.
Conditions
- Dysphagia Post Stroke
Interventions
Transcutaneous Auricular Vagus Nerve StimulationDevice
taVNS with parameters set at 250 μs , 25 HZ, and current intensity to the patient's tolerance.
Sham taVNSDevice
Sham taVNS
Primary outcomes
What the sponsor says the trial is designed to measure.
- Penetration-Aspiration Scale (PAS) scoreTime frame: At enrollment and after 4 weeks of intervention
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.